The applications of transgenic rabbits in agriculture and biomedicine

Journal of Animal and Veterinary Advances

Volumn 10, Issue 6, 2011, Pages 780-790

  Zabetian, M ^a   Tahmoorespur, M ^a   Hosseini, K ^a  

^a FERDOWSI UNIVERSITY OF MASHHAD   (Iran)

Author keywords

Bioreactor; Human disease; Microinjection; SMGT; Therapeutic protein; Transgenic rabbit

Indexed keywords

EID: 79951985253     PISSN: 16805593     EISSN: 1993601X     Source Type: Journal    
DOI: 10.3923/javaa.2011.780.790     Document Type: Article

References (101)

1. Aigner, B., K. Pambalk, U. Reichart, U. Besenfelder, Z. Bosze and M. Rentier, 1999. Species-specific alternative splicing of transgenic RNA in the mammary glands of pigs, rabbits and mice. Biochem. Biophys. Res. Commun., 257: 843-850.
2. Aigner, B., U. Besenfelder, J. Seregi, L.V. Frenyo, T. Sahin-Toth and G. Brem, 1996. Expression of the murine wild-type tyrosinase gene in transgenic rabbits. Transgenic Res., 5: 405-411.
3. Andersen, D.C. and L. Krummen, 2002. Recombinant protein expression for therapeutic applications. Curr. Opm. Biotechnol., 13: 117-123.
4. Baranyi, M., G. Brignon, P. Anglade and B. Ribadeau-Dumas, 1995. New data on the proteins of rabbit (Oryctolagus cuniculus) milk. Comp. Biochem. Physiol. B Biochem. Mol. Biol., 111: 407-415.
5. Barbagallo, CM., J. Fan, P.J. Blanche, M. Rizzo, J.M. Taylor and R.M. Krauss, 1999. Overexpression of human hepatic lipase and ApoE in transgenic rabbits attenuates response to dietary cholesterol and alters lipoprotein subclass distributions. Arterioscler. Thromb. Vase. Biol., 19: 625-632.
6. Besenfelder, U., B. Aigner, M. Muller and G. Brem, 1998. Generation and Application of Transgenic Rabbits. In: Microinjection and Transgenesis, Cid-Arregui, A. and A. Garcia-Carranca (Eds.). Springer-Verlag, New York, pp: 561-586.
7. Bodrogi, L., R. Brands, W. Raaben, W. Seinen, M. Baranyi and D. Fiechter, 2006. High level expression of tissue-nonspecific alkaline phosphatase in the milk of transgenic rabbits. Transgenic Res., 15: 627-636.
8. Bosze, Z., L. Hiripi, J.W. Carnwath and H. Niemann, 2003. The transgenic rabbit as model for human diseases and as a source of biologically active recombinant proteins. Transgenic Res., 12: 541-553.
9. Boulanger, L., S. Mallet P. Chesne, P. Chrenek, C. Viglietta and L.M. Houdebine, 2002. Advantages and limits of using ubiquitous expressed EF1 alpha promoter for transgenesis in vivo and in vitro in rabbit. Transgenic Res., 11: 88-88.
10. Brem, G., U Besenfelder, B. Aigner, M. Muller, I. Liebl and G. Schutz, 1996. YAC transgenesis in farm animals: Rescue of albinism in rabbits. Mol. Reprod. Dev., 44: 56-62.
11. Challah-Jacques, M., P. Chesne and J.P. Renard, 2003. Production of cloned rabbits by somatic nuclear transfer. Cloning Stem Cells, 5: 295-299.
12. Chapman, M.J., 1980. Animal lipoproteins: Chemistry, structure and comparative aspects. J. Lipid Res., 21: 789-853.
13. Chesne, P., P.G. Adenot, C. Vigilietta, M. Baratt, L. Boulanger and J. Renard, 2002. Cloned rabbits produced by nuclear transfer from adult somatic cells. Nat. Biotech., 20: 366-369.
14. Chrenek, P., D. Vasicek, V. Alexander, Makarevich and R. Jurcik et al., 2005. Increased transgene integration efficiency upon microinjection of DNA into both pronuclei of rabbit embryos. Transgenic Res., 14: 417-442.
15. Chrenek, P., L. Ryban, H. Vetr, A.V. Makarevich, P. Uhrin, R.K. Paleyanda and B.R. Binder, 2007. Expression of recombinant human factor VIII in milk of several generations of transgenic rabbits. Transgenic. Res., 16: 353-361.
16. Clark, A.J., 1998. Gene expression in the mammary glands of transgenic animals. Biochem. Soc. Symp., 63: 133-140.
17. Collas, P. and J.M. Robl, 1990. Factors affecting the efficiency of nuclear transplantation in the rabbit embryo. Biol. Reprod., 43: 877-884.
18. Duby, R.T., M.B. Cuniff, J.M. Belak, J.J. Bahse and J.M. Robl, 1993. Effect of milking frequency on collection of milk from nursing New Zealand white rabbits. Anim. Biotechnol., 4: 31-42.
19. Duff, G.L., 1935. Experimental cholesterol arteriosclerosis and its relationship to human arteriosclerosis. Arch. Pathol., 20: 81-123.
20. Emmanuel, F.J., M. Caillaud, N. Hennuyer, C. Fievet, I. Viry and L.M. Houdebine, 1996. Overexpression of human alipoprotein A-I inhibits atherosclerosis development in Watanabe rabbits. Circulation, 94: 10-632.
21. Fan, J. and T. Watanabe, 2000. Cholesterol-fed and transgenic rabbit models for the study of atherosclerosis. J. Atheroscler. Thromb., 7: 26-32.
22. Fan, J., H. Sun, H, Unoki, M. Shiomi and T. Watanabe, 2001. Enhanced atherosclerosis in Lp(a) WFJHL transgenic rabbits. Ann. NY Acad. Sci., 947: 362-365.
23. Fan, J., J. Wang, A. Bensadoun, S.J. Lauer, Q. Dang, R.W. Mahley and J.M. Taylor, 1994. Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins. Proc. Natl. Acad. Sci. USA., 91: 8724-8728.
24. Fan, J., M. Challah, H. Shimoyamada and T. Watanabe, 2000. Transgenic rabbits expressing human apolipoprotein(a) as a useful model for the study of hpoprotem(a). Ann. NY Acad. Sci., 902: 347-351.
25. Franz, W.M., O.J. Mueller, M. Fleischmann, P. Babij, N. Frey and M. Mueller, 1999. The 2.3 kb smooth muscle myosin heavy chain promoter directs gene expression into the vascular system of transgenic mice and rabbits. Cardiovasc Res., 43: 1040-1048.
26. Garber, K., 2000. rFactor VIII deficit questioned. Nat. Biotechnol., 18: 1133-1133.
27. Giraldo, J.L., A. Habana and A.J. Duleba, 2000. Septate uterus associated with cervical duplication and vaginal septum. J. Am. Assoc. Gynecol Laparosc, 7: 277-279.
28. Glass, C.K. and J.L. Witztum, 2001. Atherosclerosis: The road ahead. Cell, 104: 503-516.
29. Gordon, J.W. and F.H. Ruddle, 1981. Mammalian gonadal determination and gametogenesis. Sci., 4488: 1265-1271.
30. Hadlaczky, G., 2001. Satellite DNA-based artificial chromosomes for use in gene therapy. Curr. Opin. Mol. Ther.,3: 125-132.
31. Hirabayashi, M., M. Hirao, R. Takahashi, K. Kimura, K. Hirasawa and M. Ueda, 2000. Production of transgenic rabbits using centrifuged pronuclear zygotes. J. Vet. Med. Sci., 62: 1047-1052.
32. Hiripi, L., F. Makovics, R. Halter, M. Baranyi, D. Paul and J.W. Carnwath, 2003. Expression of active human blood clotting factor VIII in the mammary gland of transgenic rabbits. DNA and Cell Biol., 22: 41 -45.
33. Hoeg, J.M., S. Santamarina-Fojo, A.M. Berard, J.F. Cornhill and E.E. Herdenck et ah, 1996. Overexpression of lecithin: cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis. Proc. Natl. Acad. Sci. USA., 93: 11448-11453.
34. James, J. and J. Robbins, 1997. Molecular remodeling of cardiac contractile function. Am. J. Physiol, 273:H2105-H2118.
35. James, J., A. Sanbe, K. Yager, L. Martin, R. Klevitsky and J. Robbins, 2000. Genetic manipulation of the rabbit heart via transgenesis. Circulation, 101: 1715-1721.
36. James, J., L. Martin, M. Krenz, C. Quatman and F. Jones et at, 2005. Forced expression of alpha-myosin heavy chain in the rabbit ventricle results in cardioprotection under cardiomyopathic conditions. Circulation, 111: 2339-2346.
37. Kass, D.A., J.M. Hare and D. Georgakopoulos, 1998. Murine cardiac function: A cautionary tail. Circ. Res., 82: 519-522.
38. Kazazian, H.H., E.G.D. Tuddenham and S. Antonarakis, 1995. Haemophilia A and parahaemophilia: Deficiencies of Factor VIII and V. In: Medical and Metabolic Basis of Inherited Disease, Scriver, C, A. Beaudet, W. Sly and E. Valle (Eds.). McGraw-Hill, New York, pp: 3241-3268.
39. Kondo, M., T. Sakai, K. Komeima, Y. Kurimoto and H. Terasakil et al., 2008. Generation of a transgenic rabbit model of retinal degeneration. Invest. Ophth. Vis. Sci.,1: 2863-2871.
40. Krylov, V., T. Tlapakova, J. Macha, J. Curlej, L. Ryban and P. Chrenek, 2008. Localization of human coagulation factor VIII (hFVTII) in transgenic rabbit by FISH-TSA: Identification of transgene copy numbet and transmission to next generation. Folia Biol., 54: 121-124.
41. Kubota, C, H. Yamakuchi, J. Todoroki, K. Mizoshita and N. Tabara et al., 2000. Six cloned calves produced from adult fibroblast cells after long-term culture. Proc. Natl. Acad. Sci. USA., 97: 990-995.
42. Kupriyanov, S., K. Zeh and H. Baribault, 1998. Double pronuclei injection of DNA into zygotes increase yields of transgenic mouse lines. Transgenic Res., 7: 223-226.
43. La Ville, A., P.R. Turner, R.M. Pittilo, S. Martini, C.B. Marenah and P.M. Rowles, 1987. Hereditary hyperlipidemia in the rabbit due to overproduction of lipoproteins. I. Biochemical studies. Arteriosclerosis, 7: 105-112.
44. Larrick, J.W. and D.W. Thomas, 2001. Producing proteins in transgenic plants and animals. Curr. Opin. Biotechnol., 12: 411-418.
45. Lavitrano, M., A. Camaioni, V.M. Fazio, S. Dolci, M.G. Farace and C. Spadafora, 1989. Sperm cells as vectors for introducing foreign DNA into eggs: Genetic transformation of mice. Cell, 57: 717-723.
46. Lavitrano, M., M. Busnelli, M.G. Cemto, R. Giovannoni, S. Manzini and A. Vargiolu, 2006. Sperm-mediated gene transfer. Reprod. Fertil. Dev., 18: 19-23.
47. Lee, B.C., M.K. Kim and G. Jang, 2005. Dogs cloned from adult somatic cells. Nature, 436: 641 -641.
48. Li, L., W. Shen, L. Mm, H. Dong, Y. Sun and Q. Pan, 2006. Human lactoferrin transgenic rabbits produced efficiently using dimethylsulfoxide-sperm-mediated gene transfer. Reprod. Fertil Dev., 18: 689-695.
49. Libby, P., 2002. Inflammation in atherosclerosis. Nature, 420: 868-874.
50. Maher, V.M. and B.G. Brown, 1995. Lipoprotein (a) and coronary heart disease. Curr. Opin. Lipidol., 6: 229-235.
51. Marian, A.J., D.S. Wu Y Lim, M. McCluggage, K. Youker and Q.T. Yu, 1999. A transgenic rabbit model for human hypertrophic cardiomyopathy. J. Clin. Invest, 104: 1683-1692.
52. Massoud, M., R. Bischoff, W. Dalemans, H. Pointu and L.M. Houdebin et al., 1991. Expression of active recombinant human alpha 1 -antitrypsin in transgenic rabbits. J. Biotechnol., 18: 193-203.
53. McLeod, R.S., A.M. LeBlanc, M.A. Langille, P.L. Mitchell and D.L. Currie, 2004. Conjugated linoleic acids, atherosclerosis and hepatic very-low-density lipoprotein metabolism. Am. J. Clin. Nutr., 79: 1169-1174.
54. Molowa, D.T. and R. Mazanet, 2003. The state of biopharmaceutical manufacturing. Biotechnol. Annu. Rev., 9: 285-302.
55. Montoliu, L., 2002. Gene transfer strategies in animal transgenesis. Cloning Stem. Cells, 4: 39-46.
56. Nagueh, S.F., H.A. Kopelen, D.S. Lim, W.A. Zoghbi, M.A. Quinones and R. Roberts, 2000. Tissue Doppler imaging consistently detects myocardial contraction and relaxation abnormalities, irrespective of cardiac hypertrophy, in a transgenic rabbit model of human hypertrophic cardiomyopathy. Circulation, 102: 1346-1350.
57. Niemann, H., R. Halter, J.W. Carnwath, D. Herrmann, E. Lemme and D. Paul, 1999. Expression of human blood clotting factor VIII in the mammary gland of transgenic sheep. Transgenic Res., 8: 237-247.
58. Nishizawa, T., Y. Ishikawa, J. Sadoshima, D.E. Vatner and S.F. Vatner et at, 2007. Altered autonomic control in conscious transgenic rabbits with overexpressed cardiac Gsalpha. Am. J. Physiol. Heart. Circ. Physiol., 292: 971-976.
59. Omar, B.A., S.C. Flores and J.M. McCord, 1992. Superoxide dismutase: Pharmacological developments and applications. Adv. Pharmacol., 23: 109-161.
60. Overturf, M.L. and D.S. Loose-Mitchell, 1992. In vivo model systems: The choice of the experimental animal model for analysis of lipoproteins and atherosclerosis. Curr. Opin. Lipidol., 3: 179-185.
61. Page, R.L., S.P. Bulter, A. Subramanian, F.C. Gwazdauskas, J.L. Johnson and W.H. Velander, 1995. Transgenesis in mice by cytoplasmic injection of polylysine/DNA mixtures. Transgenic Res., 4: 353-360.
62. Paigen, B., B.Y. Ishida, J. Verstuyft, R.B. Winters and D. Albee, 1990. Atherosclerosis susceptibility differences among progenitors of recombinant inbred strains of mice. Arteriosclerosis, 10: 316-323.
63. Paleyanda, R.K., W.H. Velander, T.K. Lee, D.H. Scandella, F.C. Gwazdauskas and J.W. Knight, 1997. Transgenic pigs produce functional human factor VIII in milk. Nat. Biotechnol., 15: 971-975.
64. Palomares, L.A., S. Estrada-Mondaca and O.T. Ramirez, 2004. Production of recombinant proteins: Challenges and solutions. Methods Mol. Biol., 267: 15-52.
65. Pattison, J.S., R.J. Waggoner, J. James, L. Martin and J. Gulick et al., 2008. Phospholamban over express ion in transgenic rabbits. Transgenic Res., 17: 157-170.
66. Pursel, V.G., R.J. Wall, D.J. Bolt R.J. Palmiter and K.M. Ebert et al., 1985. Production of transgenic rabbits, sheep and pigs by microinjection. Nature, 315: 680-683.
67. Raju, T.S., J.B. Bnggs, S.M. Borge and A.J. Jones, 2000. Species-specific variation in glycosylation of IgG: evidence for the speciesspecific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics. Glycobiology, 10: 477-486.
68. Rodriguez, A., F.O. Castro, A. Aguilar, B. Ramos, D.G. Del Barco and R. Lleonart, 1995. Expression of active human erythropoietin in the mammary gland of lactating transgenic mice and rabbits. Biol. Res., 28: 141-153.
69. Ross, R., 1993. The pathogenesis of atherosclerosis: A perspective of the 1990s. Nature, 362: 801-809.
70. Rouy, D., N. Duverger, S.D. Lin, F. Emmanuel, L.M. Houdebme and P. Denefle, 1998. Apolipoprotein(a) yeast artificial chromosome transgenic rabbits. Lipoprotein(a) assembly with human and rabbit apolipoprotein B. J. Biol. Chem., 273: 1247-1251.
71. Sanbe, A., J. James, V. Tuzcu, S. Nas and L. Martin et al., 2005. A transgenic rabbit model for human troponin i-based hypertrophic. Bakken Res., 111: 2330-2338.
72. Schiaffino, S. and C. Reggiani, 1996. Molecular diversity of myofibrillar proteins: Gene regulation and functional significance. Physiol., 76: 371-423.
73. Seo, B.B., C.H. Kim, K. Yamanouchi, M. Takahashi, T. Sawasaki and C. Tachi, 2000. Co-injection of restriction enzyme 427 with foreign DNA into the pronucleus for elevating production efficiencies of transgenic animals. Anim. Reprod. Sci., 3: 113-122.
74. Shen, W., L. Li, Q. Pan, L. Mm, H. Dong and J. Deng, 2006. Efficient and simple production of transgenic mice and rabbits using the new DMSO-sperm mediated exogenous DNA transfer method. Mol. Reprod. Dev., 73: 589-594.
75. Shimizu, T.N., K. Kai, Y. Morimoto, M. Ishihara, H. Oishi, M. Kikuchi and H. Arai, 2009. Simple rabbit model of vulnerable atherosclerotic plaque. Neurologia Medico-Chirurgica, 49: 327-332.
76. Simmons, C. and D.G. Yansura, 1996. Translational level is a critical factor for the secretion of heterologous proteins in Escherichia coli. Nat. Biotechnol., 14: 629-634.
77. Simth, K. and C. Spadafora, 2005. Sperm-mediated gene transfer: Applications and implications. Bio. Essays, 27: 251-262.
78. Soler, E., A.L. Saux, F. Guinut, B. Passet and R. Cohen et al., 2005. Production of two vaccinating recombinant rotavirus proteins in the milk of transgenic rabbits. Transgenic Res., 14: 833-844.
79. Soler, E., N. Parez, B. Passet, C. Dubuquoy and S. Riffault et al., 2007. Recombinant rotavirus inner core proteins produced in the milk of transgenic rabbits confer a high level of protection after intrarectal delivery. Vaccine, 25: 6373-6380.
80. Spieker-Polet, H., P. Sethupathi, P.C. Yam and K.L. Knight, 1995. Rabbit monoclonal antibodies: Generating a fusion partner to produce rabbit-rabbit hybridomas. Proc. Natl. Acad. Sci. USA., 92: 9348-9352.
81. Stice, S.L. and J.M. Robl, 1988. Nuclear reprogramming in nuclear transplant rabbit embryos. Biol. Reprod., 39: 657-664.
82. Stromqvist, M., L.M. Houdebine, J.O. Andersson, A. Edlund and T. Johansson et al., 1997. Recombinant human extracellular superoxide dismutase produced in milk of transgenic rabbits. Transgenic Res., 6: 271-278.
83. Tall, A.R., 1993. Plasma cholesteryl ester transfer protein. J. Lipid. Res., 34: 1255-1274.
84. Tjwa, M., P. Carmeliet and L. Moons, 2006. Novel transgenic rabbit model sheds light on the puzzling role of matrix metalloproteinase-12 in atherosclerosis. Circulation, 113: 1929-1932.
85. Utermann, G., F. Hoppichler, H. Dieplinger, M. Seed, G. Thompson and E. Boerwinkle, 1989. Defects in the low density lipoprotein receptor gene affect lipoprotein (a) levels: Multiplicative interaction of two gene loci associated with premature atherosclerosis. Proc. Natl. Acad. Sci. USA., 86: 4171-4174.
86. Van Haeringen, W.A., M. den Bieman, G.F. Gillissen, A.E. Lankhorst, M.T. Kuiper, L.F. vanZutphen and H.A. van Lith, 2001. Mapping of a QTL for serum FJDL cholesterol in the rabbit using AFLP technology. J. Hered., 92: 322-326.
87. Van den Hout H., A.J. Reuser, A.G. Vulto, M.C. Loonen, A. Cromme-Dijkhuis and A.T. Van der Ploeg, 2000. Recombinant human alpha-glucosidase from rabbit milk in Pompe patients. Lancet, 356: 397-398.
88. Van denHout J.M., A.J. Reuser, J.B. de Klerk, W.F. Arts, J.A. Smeitink and A.T. van der Ploeg, 2001. Enzyme therapy for Pompe disease with recombinant human alpha-glucosidase from rabbit milk. J. Inherit. Metabiol. Dis., 24: 266-274.
89. Vasicek, D., K. Vasickova, V. Parkanyi, J. Rafay and L. Ondruska, 2007. Effective generation of genetically modified rabbites bysperm mediated gene transfer. Word Rbbit. Sci., 15: 161-166.
90. Wall, R.J., 1996. Transgenic livestock: Progress and prospects for the future. Theriogenology, 45: 57-68.
91. Wang, H.J., A.X. Lin and Y.F. Chen, 2003. Association of rabbit sperm cells with exogenous DNA. Anim. Biotechnol., 14: 155-165.
92. Watanabe, Y., 1980. Serial inbreeding of rabbits with hereditary hyperlipidemia (WHHL-rabbit). Atherosclerosis, 36: 261-268.
93. Weidle, U.H., H. Lenz and G. Brem, 1991. Genes encoding a mouse monoclonal antibody are expressed in transgenic mice, rabbits and pigs. Gene, 98: 185-191.
94. Werner, R.G., W. Noe, K. Kopp and M. Schluter, 1998. Appropriate mammalian expression systems for biopharmaceuticals. Arzneimittelforschung, 48: 870-880.
95. Wolf, E., P.M. Jehle, M.M. Weber, H. Sauerwein and A. Daxenberger et al., 1997. Human insulin-like growth factor I (IGF-I) produced in the mammary glands of transgenic rabbits: Yield, receptor binding, mitogenic activity and effects on IGF-binding proteins. Endocrinology, 138: 307-313.
96. Woods, G.L., K.L. White, D.K. Vanderwall, G.P. Li and K.I. Aston et al., 2003. A mule cloned from fetal cells by nuclear transfer. Science, 301: 1063-1063.
97. Yang, X., 1991. Embryo cloning by nuclear transfer in cattle and rabbits. Embryo Trans. News, 9: 10-22.
98. Zhang, X. J., D.L. Chinkes, A. Aarsland, D.N. Herndon and R.R. Wolfe, 2008. Lipid metabolism in diet-induced obese rabbits is similar to that of obese humans. J. Nutr. Mar., 138: 515-518.
99. Zhang, Z., J. Machac, G. Helft, S.G. Worthley and C. Tang et al., 2007. Non-invasive imaging of atherosclerotic plaque macrophage in a rabbit model with F-l 8 FDG PET: A histopathological correlation. BMC Nucl. Med., 6: 3-3.
100. Zhou, Q., J.P. Renard, G. le Friec, V. Brochard and N. Beaujean et al., 2003. Generation of fertile cloned rats by regulating oocyte activation. Science, 302: 1179-1179.
101. Zinovieva, N., C. Lassnig, D. Schams, U. Besenfelder and E. Wolf et al., 1998. Stable production of human insulin-like growth factor 1 (IGF-1) in the milk of hemi- and homozygous transgenic rabbits over several generations. Transgenic Res., 7: 437-447.